[ORGANIZATION]
National Supplementary Health Agency
Featured in 4 tracked stories · first seen
Situations
GLP-1 receptor agonist research and safety scrutiny
13 clusters · 72 sources · last updated
Latest: GLP-1 medications face scrutiny over vision loss risks and clinical developments
Research into GLP-1 receptor agonists (GLP-1 RAs) has expanded to investigate health benefits beyond glycemic control and weight loss, specifically regarding bone health, pain, and inflammation. Studies involving adults
Also covered in
-
Brazilian court orders health insurer to provide multiple sclerosis medication
[BUSINESS] · 2 sources ·
-
Medical entities issue guidance to prevent digital mammography denials
[HEALTH] · 15 sources ·